Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Stabilisation Notice - Nationwide

18 Jul 2017 14:36

RNS Number : 4106L
Societe Generale SA
18 July 2017
 

Date: 18/07/2017

Not for the distribution, directly or indirectly in to the United States or any jurisdiction in which such distribution would be unlawful.

Nationwide Building Society - Stabilisation Notice

Societe Generale (Contact: Eric Cherpion telephone: 020 7676 7618) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The Securities:

 

Issuer:

Nationwide Building Society

Guarantor (if any):

NA

Aggregate Nominal Amount:

EUR1BN

Description:

2% per annum until the Optional Redemption Date, then reset at the prevailing 5yr €MS Rate +150bp, due July 2029

Offer price:

99.503

Stabilisation:

 

Stabilising managers:

SG CIB

Stabilisation Period expected to start on:

18/07/2017

Stabilisation period expected to end no later than:

17/08/2017

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager(s) may over-allot the securities to the extent permitted in accordance with SG's Policy.

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any Stabilising action and any Stabilising action, if begun, may be ended at any time. Any Stabilising action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAOKFDNNBKDPOD
Date   Source Headline
29th Jun 202112:15 pmRNSPublication of a Base Prospectus
3rd Jun 202111:00 amRNSCirc re. Notice of Meeting
3rd Jun 202110:59 amRNSTender Offer and Consent Solicitation
24th May 20211:53 pmRNSPublication of Suppl.Prospcts
21st May 20217:00 amRNSAnnual Financial Report
5th May 20212:06 pmRNSPublication of Final Terms
1st Apr 20219:46 amRNSPublication of Suppl.Prospcts
1st Mar 20216:05 pmRNSPublication of Final Terms
1st Mar 20211:00 pmRNSAppointment of Non-Executive Director
12th Feb 20216:03 pmRNSPublication of a Prospectus
22nd Jan 202110:39 amRNSPublication of Final Terms
7th Jan 202112:32 pmRNSPublication of a Prospectus
16th Dec 202010:33 amRNSPublication of Final Terms
8th Dec 202012:47 pmRNSHolding(s) in Company
8th Dec 202012:46 pmRNSInitial admission - Offcl Lst
1st Dec 202012:17 pmRNSIssue of Equity
20th Nov 20204:08 pmRNSPublication of Suppl.Prospcts
20th Nov 20207:00 amRNSHalf-year Report
30th Oct 20201:46 pmRNSPublication of a Prospectus
18th Sep 20202:57 pmRNSResults of Tender Offers
18th Sep 202010:04 amRNSIndicative Results of Tender Offers
10th Sep 202011:24 amRNSTender Offer
1st Sep 202012:00 pmRNSDirectorate Change
27th Aug 20201:41 pmRNSPublication of Final Terms
21st Jul 20207:00 amRNSPublication of Final Terms
16th Jul 20201:35 pmRNSResult of AGM
10th Jul 20201:23 pmRNSPublication of Suppl.Prospcts
18th Jun 202010:11 amRNSInitial admission - Offcl Lst
17th Jun 20201:00 pmRNSHolding(s) in Company
15th Jun 202012:20 pmRNSPublication of a Prospectus
10th Jun 20208:32 amRNSIssue of Equity
29th May 20207:00 amRNSAnnual Financial Report
3rd Apr 20207:00 amRNSNationwide for Business
10th Mar 20207:00 amRNSDirectorate Change
13th Feb 20203:30 pmRNSPublication of Final Terms
6th Feb 20204:03 pmRNSPublication of a Prospectus
27th Jan 202011:30 amRNSPublication of Final Terms
22nd Jan 20203:00 pmRNSPublication of Final Terms
22nd Jan 20207:00 amRNSNotice to Bondholders
20th Jan 20201:00 pmRNSAppointment of Senior Independent Director
16th Dec 20195:49 pmRNSResponse to Results of BOE Stress Test 2019
25th Nov 20191:33 pmRNSPublication of Suppl.Prospcts
22nd Nov 20197:00 amRNSHalf-year Report
7th Nov 20192:04 pmRNSNotice of Pricing Results
7th Nov 20199:55 amRNSNotice of Results of Bondholder Meeting
4th Nov 201911:10 amRNSPublication of a Prospectus
16th Oct 201910:43 amRNSNotice to Bondholders
20th Sep 20195:12 pmRNSPublication of Offering Circular
13th Sep 20197:00 amRNSUpdate on Payment Protection Insurance
2nd Sep 20197:00 amRNSNon Executive Director Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.